catechin has been researched along with Amyloidosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arluison, V; Busi, F; El Hamoui, O; Turbant, F; Waeytens, J; Wien, F | 1 |
| Abskharon, R; Boyer, DR; Cheng, X; DeTure, MA; Dickson, DW; Eisenberg, DS; Ge, P; Hu, CJ; Murray, KA; Pan, H; Sawaya, MR; Seidler, PM; Vinters, HV; Williams, CK | 1 |
| Drews, T; Liu, T; Marcinko, TM; Vachet, RW | 1 |
| Aichler, M; Böddrich, A; Feuchtinger, A; Franko, A; Fuchs, H; Garg, D; Häring, HU; Hrabě de Angelis, M; Janik, D; Neff, F; Peter, A; Rathkolb, B; Reif, B; Rodriguez Camargo, A; Rodriguez Camargo, DC; Wanker, EE | 1 |
| Claus, S; Fändrich, M; Puscalau-Girtu, I; Scheller, JS | 1 |
| Andre, F; aus dem Siepen, F; Buss, SJ; Giannitsis, E; Katus, HA; Kristen, AV; Seitz, S; Steen, H | 1 |
| Amero, C; French-Pacheco, L; Maya-Martinez, R; Pastor, N; Pelaez-Aguilar, AE; Rivillas-Acevedo, L; Valdes-Garcia, G | 1 |
| Bano, B; Bhat, SA; Bhat, WF | 1 |
| Akaji, K; Kashiwada, Y; Kawashima, H; Kobayashi, N; Kuwabara, K; Mikawa, S; Nakajima, H; Nishitsuji, K; Saito, H; Sakashita, N; Uchimura, K | 1 |
| Goto, M; Hotta, M; Kobayashi, M; Meshitsuka, S; Nojima, M; Sagesaka, YM; Shingaki, S; Suzuki, K; Ukawa, Y; Wada, Y | 1 |
| Andrich, K; Bergen, HR; Bieschke, J; Hegenbart, U; Kedia, N; Kimmich, C; Schönland, S; Wanker, E | 1 |
| Buss, SJ; Hardt, SE; Hunstein, W; Katus, HA; Mereles, D | 1 |
| Almeida, MR; Ferreira, N; Saraiva, MJ | 1 |
| Ehrhart, J; Hardy, J; Hou, H; Jeanniton, D; Morgan, D; Mori, T; Rezai-Zadeh, K; Shytle, D; Sun, N; Tan, J; Town, T; Townsend, K; Zeng, J | 1 |
| Hunstein, W | 1 |
2 trial(s) available for catechin and Amyloidosis
| Article | Year |
|---|---|
Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
Topics: Administration, Oral; Aged; Amyloid; Amyloidosis; Camellia sinensis; Capsules; Cardiomyopathies; Catechin; Contrast Media; Extracellular Matrix; Fibrosis; Gadolinium DTPA; Germany; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Myocardium; Plant Extracts; Predictive Value of Tests; Time Factors; Treatment Outcome; Ventricular Remodeling | 2015 |
Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Antioxidants; Catechin; Female; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Tea; Treatment Outcome | 2017 |
13 other study(ies) available for catechin and Amyloidosis
| Article | Year |
|---|---|
Evaluation of Amyloid Inhibitor Efficiency to Block Bacterial Survival.
Topics: Amyloid; Amyloidogenic Proteins; Amyloidosis; Anti-Bacterial Agents; Bacteria; Catechin; Humans | 2022 |
Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro.
Topics: Alzheimer Disease; Amyloid; Amyloidosis; Catechin; Cryoelectron Microscopy; Drug Evaluation, Preclinical; Humans; tau Proteins; Tea | 2022 |
Epigallocatechin-3-gallate Inhibits Cu(II)-Induced β-2-Microglobulin Amyloid Formation by Binding to the Edge of Its β-Sheets.
Topics: Amyloid; Amyloidogenic Proteins; Amyloidosis; beta 2-Microglobulin; Catechin; Chromatography, Gel; Copper; Humans; Mass Spectrometry; Models, Molecular; Protein Conformation, beta-Strand; Protein Multimerization | 2020 |
Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.
Topics: Amyloid; Amyloidosis; Animals; Biomarkers; Catechin; Humans; Islet Amyloid Polypeptide; Mice; Mice, Transgenic; Models, Molecular; Molecular Conformation; Neuroprotective Agents; Pancreas; Protein Binding | 2018 |
Cell assay for the identification of amyloid inhibitors in systemic AA amyloidosis.
Topics: Amyloidosis; Animals; Biological Assay; Catechin; Cell Line, Tumor; Humans; Mice; Models, Biological; Protein Aggregation, Pathological; Serum Amyloid A Protein | 2019 |
Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amyloid; Amyloidosis; Catechin; Humans; Immunoglobulin Light Chains; In Vitro Techniques; Melatonin; Microscopy, Electron, Transmission; Models, Molecular; Molecular Sequence Data; Mutation, Missense; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Protein Multimerization; Quercetin; Recombinant Proteins; Rifampin; Tetracycline | 2015 |
Evaluation of polyphenols as possible therapeutics for amyloidoses: Comparative analysis of Kaempferol and Catechin.
Topics: Amyloid; Amyloidosis; Animals; Brain; Catechin; Circular Dichroism; Cystatins; Goats; Hydrogen-Ion Concentration; Kaempferols; Polyphenols; Protein Aggregation, Pathological; Protein Structure, Secondary; Spectrometry, Fluorescence | 2015 |
The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
Topics: Amyloid; Amyloidosis; Apolipoprotein A-I; Catechin; Cell Survival; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Protein Aggregation, Pathological; Protein Structure, Secondary; Reactive Oxygen Species | 2016 |
Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.
Topics: Amyloid; Amyloidosis; Catechin; Circular Dichroism; Electrophoresis, Polyacrylamide Gel; Humans; Immunoglobulin Light Chains; Kinetics; Spectrometry, Fluorescence; Thermodynamics | 2017 |
Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis.
Topics: Aged; Amyloidosis; Catechin; Female; Humans; Male; Middle Aged; Plant Extracts; Tea; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation.
Topics: Amyloid; Amyloidosis; Catechin; Curcumin; Flavonoids; Phenols; Polyphenols; Prealbumin; Protein Binding; Protein Multimerization | 2011 |
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Catechin; Cells, Cultured; Female; Flavonoids; Mice; Mice, Transgenic; Tea | 2005 |
Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?
Topics: Amyloidosis; Anticarcinogenic Agents; Catechin; Humans; Protease Inhibitors | 2007 |